Immune checkpoint inhibitors induce response in a dose-dependent manner while their immune related adverse events are dose-independent, a meta-analysis

被引：0
|
作者：
Rahma, Osama [1 ]
Reuss, Joshua [2 ]
Giobbie-Hurder, Anita [1 ]
Razavi, Ghazaleh [3 ]
Mehra, Pooja [4 ]
Gupta, Seema [5 ]
Elias, Rawad [6 ]
Khleif, Samir [5 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Georgia Canc Ctr, Augusta, GA USA
[4] Univ Virginia, Charlottesville, VA USA
[5] Georgetown Univ, Washington, DC USA
[6] Hartford Healthcare, Hartford, CT USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P265
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis
    Baohui Hong
    Bin Du
    Rong Chen
    Caiyun Zheng
    Ruping Ni
    Maobai Liu
    Jing Yang
    BMC Medicine, 22
  • [32] Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis
    Hong, Baohui
    Du, Bin
    Chen, Rong
    Zheng, Caiyun
    Ni, Ruping
    Liu, Maobai
    Yang, Jing
    BMC MEDICINE, 2024, 22 (01)
  • [33] The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors
    Wang, Min
    Zhai, Xiaoyang
    Li, Ji
    Guan, Jingyuan
    Xu, Shuhui
    Li, YuYing
    Zhu, Hui
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
    Nso, Nso
    Antwi-Amoabeng, Daniel
    Beutler, Bryce D.
    Ulanja, Mark B.
    Ghuman, Jasmine
    Hanfy, Ahmed
    Nimo-Boampong, Joyce
    Atanga, Sirri
    Doshi, Rajkumar
    Enoru, Sostanie
    Gullapalli, Nageshwara
    WORLD JOURNAL OF CARDIOLOGY, 2020, 12 (11): : 584 - 598
  • [35] Retrospective Analysis of Immune Checkpoint Inhibitors in NSCLC: Immune-Related Adverse Events and Outcomes
    Lee, A.
    Luong, M.
    Ohana, D.
    Forster, M.
    Lee, S. M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S734 - S735
  • [36] PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis
    Jiaying Wu
    Dongsheng Hong
    Xiangnan Zhang
    Xiaoyang Lu
    Jing Miao
    Scientific Reports, 7
  • [37] Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
    El Osta, B.
    Hu, F.
    Sadek, R.
    Chintalapally, R.
    Tang, S. -C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 1 - 12
  • [38] Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
    Zhang, Shuo
    Zhou, Ziyue
    Wang, Li
    Li, Mengtao
    Zhang, Fengchun
    Zeng, Xiaofeng
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [39] Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
    Zhao, Qing
    Zhang, Jianwei
    Xu, Lingyi
    Yang, Huaxia
    Liang, Naixin
    Zhang, Li
    Zhang, Fengchun
    Zhang, Xuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors
    Gandhi, Shipra
    Pandey, Manu
    Ammannagari, Nischala
    Wang, Chong
    Bucsek, Mark J.
    Hamad, Lamya
    Repasky, Elizabeth
    Ernstoff, Marc S.
    IMMUNOTHERAPY, 2020, 12 (02) : 141 - 149
12345